ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    CD4+ T Cell Differentiation and Belatacept Resistant Rejection

    J. Espinosa, J. Cheeseman, A. Mehta, L. Stempora, R. Townsend, A. Kirk

    Emory University, Atlanta, GA; Bristol-Myers Squibb, Princeton, NJ

    Purpose: T cells with a memory phenotype mediate costimulation blockade (CoB) resistant rejection (RR), and early CoBRR has been seen in patients on belatacept-based immunosuppression.…
  • 2013 American Transplant Congress

    Evolution of SPK Transplant in Type I and Type II Diabetics with End Stage Renal Disease: The 20 Year Experience, The

    J. Light, M. Tucker, M. Orquiza

    Surgery, Washington Hospital Center, Washington, DC

    Introduction: There continues to be much debate whether Type II diabetics can benefit from a SPK. We are reporting our 20 years experience in patients…
  • 2013 American Transplant Congress

    Worse Long Term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients with a History of Smoking

    J. Bell, R. Mangus, J. Fridell, R. Vianna, C. Kubal, S. Tiwari, A. Tector

    Transplant Division, Dept of Surgery, Indiana University School of Medicine, Indianapolis, IN

    IntroductionTobacco use is associated with multiple medical problems including an increased risk of cancer (CA). The risk of CA is increased in the post-transplant period.…
  • 2013 American Transplant Congress

    Burden of OPTN Data Submission: Far More Than Estimated

    K. Xu, L. Preczewski, G. McNatt, D. Ladner

    Northwestern University, Chicago, IL; University of California, Davis, Sacromento, CA

    Background: The United Network for Organ Sharing (UNOS) holds an exclusive federal contract as the Organ Procurement and Transplantation Network (OPTN) to allocate deceased donor…
  • 2013 American Transplant Congress

    Risk Factors Associated with Surgical Complications in Recipients of Kidneys from Very Small Pediatric Donors

    R. Perez, A. Demattos, C. Santhanakrishnan, J. McVicar, M. Gandhi, B. Gallay, D. Adey, M. Alnimri, C. Troppmann

    UC Davis Transplant Center, Sacramento, CA

    Transplantation of kidneys from very small pediatric donors is associated with a high rate of surgical complications and graft loss. We examined our series of…
  • 2013 American Transplant Congress

    Liver Transplant Program Quality Index Which Accounts for Transplant Rate; the Power of Numbers!, A

    C. Rochon, A. Lally, M. Brown, P. Sheiner

    Surgery/Transplantation, Hartford Hospital, Hartford, CT

    It is unclear whether patients and grafts survival (PS and GS) rates alone are indices of Quality. Programs who cherry pick could have outstanding PS/GS…
  • 2013 American Transplant Congress

    Targeting of mTORC2 in DC Elicits an Enhanced Pro-Inflammatory Profile and Th17 Alloresponse

    D. Raich-Regue, B. Rosborough, K. Lee, M. Boothby, H. Turnquist, A. Thomson

    Department of Surgery and Department of Immunology, Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN

    Mammalian target of rapamycin (mTOR) is an important, yet poorly understood integrative kinase that regulates immune cell function. mTOR functions in two independent complexes,- mTOR…
  • 2013 American Transplant Congress

    Pronounced Impact of Community Risk Factors on Pre-Transplant Kidney Candidate Processes and Outcomes

    E. Heaphy, L. Buccini, T. Srinivas, E. Poggio, D. Goldfarb, S. Flechner, J. Rodrigue, D. Thornton, A. Sehgal, J. Schold

    Cleveland Clinic, Cleveland; Medical University of South Carolina, Charelston; Beth Israel Deaconess Medical Center, Boston; Case Western Reserve University, Cleveland

    IntroductionThere are many potential factors which are associated with patient outcomes beyond traditional clinical and donor characteristics.MethodsWe merged national SRTR data with data aggregated from…
  • 2013 American Transplant Congress

    Fish Oil Diet Overcomes Genetic Predisposition Restoring Hepatocyte Proliferation in Livers of A20 Heterozygous Mice Following Partial Hepatectomy

    C. Da Silva, P. Studer, E. Csizmadia, D. Minussi, K. Daniels, C. Ferran

    Surgery, Beth Israel Deaconess Medical Center - HMS, Boston, MA

    Increased free fatty acids (FA) metabolism following partial hepatectomy (PH) is required to meet energy demands of liver regeneration (LR). Impact of dietary lipid intake…
  • 2013 American Transplant Congress

    French Uncontrolled Donors after Circulatory Arrest (Udcd) Program for Kidney Transplantation: Procurement Procedure Efficiency and 3-Month Survival Results

    C. Antoine, E. Savoye, L. Jacob, G. Cheisson, B. Riou, L. Badet, M. Videcoq, G. Strecker, M. Thuong, National Steering Committee Non Heart Beating Donors Group

    Biomedecine Agency, La Plaine Saint Denis, France; Department of Anesthesia and Critical Care, Saint Louis Hospital, Paris, France; Department of Anesthesia and Critical Care, Bicetre Hospital, Kremlin Bicetre, France; Emergency Department, La Pitié Salpêtrière Hospital, Pitié, France; Department of Transplantation, Edouard Herriot Hospital Group, Lyon, France; Department of Anesthesia and Critical Care, Hôtel-Dieu Hospital, Nantes, France; Department of Anesthesia and Critical Care, Huriez Hospital, Lille, France

    The national protocol for the uDCD program restricts the no flow period to <30 min and the total warm ischemia time (WIT) to <150 min.…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences